GlassScriptPhysician profile
Steven M Spinner
NPI 1902954217
$7,027.96
in general payments reported to CMS, 2019-2025
30 companies · $597 in 2025
The $597 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,159 · 2020: $870 · 2021: $1,204 · 2022: $992 · 2023: $686 · 2024: $520 · 2025: $597.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,803.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,290.90 | 2019-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Wright Medical Technology, INC. | $1,256.75 | 2019 | |
| Integra Lifesciences Corporation | $768.46 | 2019-2021 | |
| Stryker Corporation | $549.29 | 2019-2025 | Prostep Mica, Augment Injectable, Infinity |
| Smith+Nephew, INC. | $314.72 | 2023-2025 | Stravix Pl, Grafix Pl, Oasis |
| Zimmer Biomet Holdings, INC. | $309.23 | 2020-2022 | |
| Paratek Pharmaceuticals, INC. | $268.30 | 2021-2023 | Nuzyra |
| Treace Medical Concepts, INC. | $218.62 | 2023 | |
| Paragon 28, INC. | $213.61 | 2019-2022 | |
| Acell, INC. | $210.21 | 2019-2020 | |
| Polynovo North America LLC | $156.37 | 2025 | Novosorb Btm |
| Biotissue Holdings INC. | $156.00 | 2021-2023 | |
| Orthofix Medical, INC. | $155.45 | 2021 | |
| Flower Orthopedics Coporation | $150.00 | 2020 | |
| Nevro Corp. | $146.97 | 2022 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $119.79 | 2021 | |
| Boston Scientific Corporation | $108.97 | 2019 | |
| Bard Peripheral Vascular, INC. | $107.15 | 2019 | |
| Ethicon US, LLC | $100.12 | 2022 | |
| Organogenesis INC. | $92.99 | 2020-2021 | |
| Misonix INC | $74.69 | 2020 | |
| Medtronic, INC. | $74.69 | 2023 | Venaseal |
| Linvatec Corporation | $46.48 | 2019-2025 | Biobrace 23mm |
| Crossroads Extremity Systems, LLC | $41.93 | 2019 | |
| Djo, LLC | $26.06 | 2023 | Cmf |
| Bioventus LLC | $17.32 | 2019 | |
| Sebela Pharmaceuticals INC. | $15.33 | 2019 | |
| Zyla Life Sciences, INC. | $14.85 | 2019 | |
| Depuy Synthes Sales INC. | $11.65 | 2022 | |
| Amniox Medical, INC. | $11.06 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Spinner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.